Food ingredient suppliers ICL Performance Products and BK Giulini,with previously separate sales and marketing groups within ICL PP in North America,have combined to form the new North American food division ICL Food Specialties. The new ...
Tags: food ingredient, food, beverage
Torque’s imaginative and unique approach to providing its clients with a truly comprehensive ‘end to end service’ is further underlined with its latest investment - a state of the art embroidery centre, the only company in ...
Tags: embroidery equipment, embroidery, art embroidery centre
SJH2O has partnered with Swarovski to create a unique luxury swimwear collection debuting in the Spring/Summer 2013. The swimwear will feature the "MADE WITH SWAROVSKI ELEMENTS" label that will serve as a certificate of authenticity ...
Tags: SJH2O, Swarovski, luxury swimwear, swimwear collection
US based electric motor systems manufacturer KLD Energy Technologies has partnered with diesel and LPG powertrains maker Cenntro Group to develop 4-wheel electric vehicles (EVs) that incorporate KLD's electric vehicle drive system ...
ChromaDex has entered into a distribution agreement with Glanbia Nutritionals for its patented pTeroPure(pterostilbene). Under the agreement,Glanbia Nutritionals will serve as the exclusive distributor of pTeroPure to the food,beverage ...
Tags: distribution agreement, dietary supplement, antioxidant, beverage
The Board of Xennia Technology Ltd announces the appointment of Mr Dave Knight as managing director with effect from the 17th September, 2012. Dave Knight brings to Xennia Technology a strong track record in strategic and brand ...
Tags: ink, ink systems, Textile applications, textile market
The government has granted a North Yorkshire egg processor£490,000 towards the construction of a£3M egg processing facility. Chippendale is to build a new£3M egg processing facility The move will secure 40 jobs at ...
Tags: egg processing facility, North Yorkshire, Rural Development Programme
Teva UK, a part of Teva Pharmaceutical Industries, has introduced the generic atorvastatin film-coated tablets in 10mg, 20mg, 40mg and 80mg strengths in the UK. The generic version of Pfizer's Lipitor is indicated for the treatment of ...
Tags: Teva UK, film-coated tablets, treatment of hypercholesterolaemia
Textile Testing Workshop to be held December 5-6 at the American Association of Textile Chemists and Colorists (AATCC) headquarters in Research Triangle Park, N.C., USA. AATCC procedures for evaluating colorfastness and physical ...
Tags: Textile Testing Workshop, Textile Chemists, Textile Fabrics
ACE Bakery,a producer of baked goods,plans to invest$18.4m to set up a new facility in Cherokee County,South Carolina,US The facility will produce the company's artisan line of baked breads for both the retail and foodservice sectors.It ...
Tags: baked goods, new facility, foodservice sectors, preservatives
Japanese carmaker Toyota Motor (TMC) is planning to increase its annual engine assembly capacity of cby 100,000 units at its Kentucky plant in US. The plan, to be executed under $30m project, will facilitate the company to increase the ...
Tags: Toyota Motor, annual engine, carmaker, engine production
Teva, a provider of generic pharmaceutical drugs, has introduced Rivastigmine capsules for generic prescription. Rivastigmine is generic equivalent to Novartis' Exelon capsules. Rivastigmine is indicated for use in the symptomatic ...
Tags: Teva, rivastigmine, Novartis'Exelon capsules
The Arab state of Oman is hopeful that India will lift the anti-dumping duty imposed on polypropylene (PP) manufactured in Oman since December 2010. Oman’s Ministry of Commerce said it is negotiating with the Indian ...
Tags: anti-dumping duty, polypropylene, polypropylene exports
Cabela's Incorporated reported strong financial results for third quarter fiscal 2012. For the quarter, total revenue increased 9.2% to $741.2 million; Retail store revenue increased 15.8% to $456.0 million; Direct revenue decreased 6.7% ...
Tags: Cabela's, financial results, third quarter, revenue
Human Genome Sciences (HGS) has rejected $2.6bn (£1.6bn) takeover bid offered by GlaxoSmithKline (GSK). GSK offered $13 per share, which is 81% premium to HGS closing price on 18 April 2012, of $7.17 per share. HGS has partnered ...
Tags: HGS, GSK, GlaxoSmithKline